IBDEI2JT ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,43229,2)
 ;;=^5000967
 ;;^UTILITY(U,$J,358.3,43230,0)
 ;;=C34.92^^164^2066^10
 ;;^UTILITY(U,$J,358.3,43230,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43230,1,3,0)
 ;;=3^Malig Neop,Unspec Part,Lt Bronchus/Lung
 ;;^UTILITY(U,$J,358.3,43230,1,4,0)
 ;;=4^C34.92
 ;;^UTILITY(U,$J,358.3,43230,2)
 ;;=^5000968
 ;;^UTILITY(U,$J,358.3,43231,0)
 ;;=J20.9^^164^2066^3
 ;;^UTILITY(U,$J,358.3,43231,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43231,1,3,0)
 ;;=3^Bronchitis,Acute
 ;;^UTILITY(U,$J,358.3,43231,1,4,0)
 ;;=4^J20.9
 ;;^UTILITY(U,$J,358.3,43231,2)
 ;;=^5008195
 ;;^UTILITY(U,$J,358.3,43232,0)
 ;;=J42.^^164^2066^4
 ;;^UTILITY(U,$J,358.3,43232,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43232,1,3,0)
 ;;=3^Bronchitis,Chronic
 ;;^UTILITY(U,$J,358.3,43232,1,4,0)
 ;;=4^J42.
 ;;^UTILITY(U,$J,358.3,43232,2)
 ;;=^5008234
 ;;^UTILITY(U,$J,358.3,43233,0)
 ;;=J45.909^^164^2066^2
 ;;^UTILITY(U,$J,358.3,43233,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43233,1,3,0)
 ;;=3^Asthma,Unspec,Uncomplicated
 ;;^UTILITY(U,$J,358.3,43233,1,4,0)
 ;;=4^J45.909
 ;;^UTILITY(U,$J,358.3,43233,2)
 ;;=^5008256
 ;;^UTILITY(U,$J,358.3,43234,0)
 ;;=J45.902^^164^2066^1
 ;;^UTILITY(U,$J,358.3,43234,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43234,1,3,0)
 ;;=3^Asthma,Unspec, w/ Status Asthmaticus
 ;;^UTILITY(U,$J,358.3,43234,1,4,0)
 ;;=4^J45.902
 ;;^UTILITY(U,$J,358.3,43234,2)
 ;;=^5008255
 ;;^UTILITY(U,$J,358.3,43235,0)
 ;;=J61.^^164^2066^15
 ;;^UTILITY(U,$J,358.3,43235,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43235,1,3,0)
 ;;=3^Pneumoconiosis d/t Asbest & Oth Min Fibers
 ;;^UTILITY(U,$J,358.3,43235,1,4,0)
 ;;=4^J61.
 ;;^UTILITY(U,$J,358.3,43235,2)
 ;;=^5008262
 ;;^UTILITY(U,$J,358.3,43236,0)
 ;;=R09.1^^164^2066^14
 ;;^UTILITY(U,$J,358.3,43236,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43236,1,3,0)
 ;;=3^Pleurisy
 ;;^UTILITY(U,$J,358.3,43236,1,4,0)
 ;;=4^R09.1
 ;;^UTILITY(U,$J,358.3,43236,2)
 ;;=^95428
 ;;^UTILITY(U,$J,358.3,43237,0)
 ;;=J84.10^^164^2066^16
 ;;^UTILITY(U,$J,358.3,43237,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43237,1,3,0)
 ;;=3^Pulmonary Fibrosis,Unspec
 ;;^UTILITY(U,$J,358.3,43237,1,4,0)
 ;;=4^J84.10
 ;;^UTILITY(U,$J,358.3,43237,2)
 ;;=^5008300
 ;;^UTILITY(U,$J,358.3,43238,0)
 ;;=R91.1^^164^2066^17
 ;;^UTILITY(U,$J,358.3,43238,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43238,1,3,0)
 ;;=3^Pulmonay Nodule,Solitary
 ;;^UTILITY(U,$J,358.3,43238,1,4,0)
 ;;=4^R91.1
 ;;^UTILITY(U,$J,358.3,43238,2)
 ;;=^5019707
 ;;^UTILITY(U,$J,358.3,43239,0)
 ;;=B49.^^164^2067^52
 ;;^UTILITY(U,$J,358.3,43239,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43239,1,3,0)
 ;;=3^Mycosis,Unspec
 ;;^UTILITY(U,$J,358.3,43239,1,4,0)
 ;;=4^B49.
 ;;^UTILITY(U,$J,358.3,43239,2)
 ;;=^5000690
 ;;^UTILITY(U,$J,358.3,43240,0)
 ;;=C49.9^^164^2067^51
 ;;^UTILITY(U,$J,358.3,43240,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43240,1,3,0)
 ;;=3^Malig Neop Connective & Soft Tissue,Unspec
 ;;^UTILITY(U,$J,358.3,43240,1,4,0)
 ;;=4^C49.9
 ;;^UTILITY(U,$J,358.3,43240,2)
 ;;=^5001136
 ;;^UTILITY(U,$J,358.3,43241,0)
 ;;=E11.9^^164^2067^19
 ;;^UTILITY(U,$J,358.3,43241,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43241,1,3,0)
 ;;=3^Diabetes Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,43241,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,43241,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,43242,0)
 ;;=E10.9^^164^2067^18
 ;;^UTILITY(U,$J,358.3,43242,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43242,1,3,0)
 ;;=3^Diabetes Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,43242,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,43242,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,43243,0)
 ;;=D50.0^^164^2067^48
